Effect of Transcranial Direct-current Stimulation in Eating Behavior of Women With Fibromyalgia
Fibromyalgia, Food Addiction
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring polymorphism Taq1A, tDCS, dopamine, eating behavior
Eligibility Criteria
Inclusion criteria:
- Right-handers who can read and write,
- Confirmed diagnosis of FM
- Pain score of six or more on the Numerical Pain Scale (SPN 0-10) on most days of the last 3 months.
Exclusion criteria:
Living outside the Greater Porto Alegre area and pregnancy. Contraindications to EMT and ETCC: metallic implant in the brain; medical devices implanted in the brain, cardiac pacemaker; cochlear implant; history of alcohol or drug abuse in the last 6 months; neurological disorders; hx of head trauma or neurosurgery; decompensated systemic diseases, and chronic inflammatory diseases (lupus, rheumatoid arthritis, Sjogren's syndrome, Reiter's syndrome); uncompensated hypothyroidism; personal history of cancer, past or under treatment. Weight loss use and bariatric surgery.
Sites / Locations
- Hospital de Clinicas de Porto Alegre
- Wolnei CaumoRecruiting
Arms of the Study
Arm 1
Arm 2
Sham Comparator
Experimental
sham tDCS
active tDCS
For sham treatment we will use the same assembly as the active ETCC. However, we will apply the current for 30s at the start of the stimulation session and 30s at the end of the session.
The anode will be positioned over the left hemisphere at C3 while the cathode will be positioned over the contralateral hemisphere F3. During active stimulation a 2.0mA current released by a 35 cm2 electrode will be used for 20 min. The position of the electrodes will be performed based on a 10-20 system according to the international EEG unit system, with the location of the electrodes at C3 and F3, respectively.